首页> 美国卫生研究院文献>Journal of Pain Research >Current pain management strategies for patients with erythromelalgia: a critical review
【2h】

Current pain management strategies for patients with erythromelalgia: a critical review

机译:当前红斑性痛患者的疼痛治疗策略:一项重要的评论

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Erythromelalgia (EM) is a rare disorder characterized by erythematous, warm, painful extremities, which is often precipitated by cold conditions. The pathophysiology of EM is incompletely understood. Recent investigations have identified sodium channelopathy as a genetic cause for this pain condition, classified as primary inherited EM. Other subtypes are idiopathic EM and secondary EM. The management of pain in EM is challenging as no single therapy has been found to be effective. There is varying response to pharmacotherapy and significant variability within this clinical population, resulting in a stepwise trial and error approach. Consequently, EM is often associated with poorer health-related quality of life with higher morbidity. There is currently no consensus or guidelines on management of pain in EM. This is a review of the literature on management of pain using pharmacologic, procedural intervention and nonpharmacologic treatment in children and adults with EM.
机译:红血淋病(EM)是一种罕见的疾病,其特征是四肢红斑,温暖,疼痛,通常是由于寒冷而引起的。 EM的病理生理学尚未完全理解。最近的研究已将钠通道病定为该疼痛状况的遗传原因,被归为原发性遗传性EM。其他亚型是特发性EM和继发性EM。 EM的疼痛处理具有挑战性,因为没有发现一种有效的疗法。在这一临床人群中,对药物治疗的反应各不相同,并且变异性很大,因此需要逐步进行尝试和尝试。因此,EM通常与健康相关的生活质量较差,发病率较高有关。目前尚无关于EM疼痛管理的共识或指南。本文是有关使用药物,程序干预和非药物疗法治疗EM儿童和成人疼痛的文献综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号